Robert Richardson, MD
Neurological Surgery · Boston, MANPI 1962527192
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $123,525 of the $189,841 with a category attached, or 65.1%. 13 manufacturers reported payments, led by Neuropace, Inc. at 45.4% of the total. Reporting peaked in 2024 at $70,557 and has fallen 54.3% since, to $32,261 in 2025. Among neurological surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $1123.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuropace, Inc.$86K
- Zimmer Biomet$37K
- Medtronic$29K
- Clearpoint Neuro, Inc.$12K
- Spark Therapeutics, Inc.$9K
- Boston Scientific$5K
- plus $11K from 7 others
Across 191 payments — averaging $2248.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$293K
- Neuropace, Inc.$91K
- Medtronic$28K
- Abbott$17K
What the payments were for
- Consulting fees$123,52565%
- Speaking & faculty fees$18,78010%
- Travel & lodging$38,80520%
- Food & beverage$8,7315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuropace, Inc. | 82 | $86,187 |
| Zimmer Biomet | 18 | $37,460 |
| Medtronic(2 entities) | 15 | $29,377 |
| Clearpoint Neuro, Inc. | 30 | $12,151 |
| Spark Therapeutics, Inc. | 2 | $8,645 |
| Boston Scientific | 9 | $5,186 |
| F. Hoffmann-la Roche AG | 1 | $5,075 |
| Neurocrine Biosciences, Inc. | 1 | $2,500 |
| Biogen | 1 | $1,695 |
| Monteris Medical Corporation | 4 | $1,042 |
| Neuroone Medical Technologies Corporation | 1 | $274 |
| Bayer | 4 | $231 |
| Abbott | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RNS Neurostimulator Kit$81,594
- ACTIVA$23,773
- ROSA$19,518
- CLEARPOINT$9,065
- GENERAL DBS$4,000
- RNS System$3,866
- ClearPoint Neuro Workstation$1,750
- Neuroblate$1,000
- ClearPoint System$896
- GENERAL - THERAPIES$814
How this compares
$189,841 in reported general payments places this provider in the 90th percentile of 183 neurological surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Boston
- Simcha WellerBoston$905K
- Aman PatelBoston$734K
- Alireza AtriBoston$503K
- Myron RolleBoston$290K
- John ChiBoston$280K
- Philipp TausskyBoston$224K
- Brendon BootBoston$149K
- Muhammad Abd-El-BarrBoston$140K
- Brian NahedBoston$97K
- Thomas NohBoston$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.